Showing 1 to 4 of 4 results


World-First Chlamydia Vaccine Approved for Koalas
Australia has approved a world-first single-dose vaccine for koalas to combat chlamydia, a leading cause of death among the marsupials, with trials showing a 64% reduction in chlamydia-related deaths.
World-First Chlamydia Vaccine Approved for Koalas
Australia has approved a world-first single-dose vaccine for koalas to combat chlamydia, a leading cause of death among the marsupials, with trials showing a 64% reduction in chlamydia-related deaths.
Progress
40% Bias Score


Sharp Rise in European STIs in 2023
European STI rates surged in 2023, with nearly 100,000 gonorrhea cases (a fourfold increase from a decade ago) and a 13% rise in syphilis cases, mainly impacting men who have sex with men; this is possibly due to decreased condom use, improved testing, or a combination of factors, and contrasts with...
Sharp Rise in European STIs in 2023
European STI rates surged in 2023, with nearly 100,000 gonorrhea cases (a fourfold increase from a decade ago) and a 13% rise in syphilis cases, mainly impacting men who have sex with men; this is possibly due to decreased condom use, improved testing, or a combination of factors, and contrasts with...
Progress
44% Bias Score

Australia Approves World-First Koala Chlamydia Vaccine
Australia has approved a world-first vaccine to combat the chlamydia epidemic decimating its koala population, a disease responsible for up to half of koala deaths in the wild, with some colonies facing extinction.

Australia Approves World-First Koala Chlamydia Vaccine
Australia has approved a world-first vaccine to combat the chlamydia epidemic decimating its koala population, a disease responsible for up to half of koala deaths in the wild, with some colonies facing extinction.
Progress
24% Bias Score

Doxycycline Shows Promise in Slashing STI Rates
A Harvard study of 2,253 individuals found that taking the antibiotic doxycycline within 72 hours of sex reduced chlamydia and syphilis infection rates by up to 80 percent, prompting calls for wider availability despite concerns about antimicrobial resistance.

Doxycycline Shows Promise in Slashing STI Rates
A Harvard study of 2,253 individuals found that taking the antibiotic doxycycline within 72 hours of sex reduced chlamydia and syphilis infection rates by up to 80 percent, prompting calls for wider availability despite concerns about antimicrobial resistance.
Progress
48% Bias Score
Showing 1 to 4 of 4 results